Buscar en
Radiología (English Edition)
Toda la web
Inicio Radiología (English Edition) Immunotherapy in oncology: A new challenge for radiologists
Journal Information
Vol. 61. Issue 2.
Pages 134-142 (March - April 2019)
Download PDF
More article options
Vol. 61. Issue 2.
Pages 134-142 (March - April 2019)
Radiology through images
Immunotherapy in oncology: A new challenge for radiologists
Inmunoterapia en oncología: un nuevo desafío radiológico
A. Bustos Fiore
Corresponding author
, A. Banguero Gutiérrez, L. Guerrero Acosta, C. Segura Cros, R. Ramos de la Rosa
Hospital Universitario Quirón Dexeus, Barcelona, Spain
Article information
Full Text
Download PDF
Figures (11)
Show moreShow less
Tables (1)
Table 1. Adverse effects of immunotherapy.

In patients with oncologic disease, immunotherapy has become established as an alternative or complementary therapy to traditional treatment options (surgery, radiotherapy, and chemotherapy). Currently available immunotherapy modes can be divided into two types: passive and active. The active type strengthens the immune system's response to tumour cells by activating both humoral immunity and cell-mediated immunity, using the adaptive response. This article aims to analyse the radiologic patterns of the response to immunotherapy through immune-response-related criteria and to describe the main adverse effects associated with this treatment approach.


Imaging tests play a fundamental role in the follow-up of oncologic patients and in the assessment of their response to treatment. Immunotherapy represents a challenge for radiologists both in the evaluation of the response to immunotherapy and in the detection of the adverse effects associated with this treatment approach.

Imaging in oncology
Directed molecular therapy
Criteria for immune response
Adverse events

La inmunoterapia en oncología se ha establecido como una terapia alternativa o complementaria al tratamiento tradicional (cirugía, radioterapia y quimioterapia). La inmunoterapia disponible actualmente se divide en dos categorías: pasiva y activa. La respuesta activa refuerza el sistema inmune para responder frente a las células tumorales activando tanto la inmunidad humoral como la celular, utilizando la respuesta adaptativa. El objetivo de este trabajo es valorar los patrones radiológicos de respuesta al tratamiento inmunológico mediante los criterios de respuesta relacionados con la inmunidad (immune related response criteria [irRC]) y describir los principales efectos adversos asociados.


Las pruebas de imagen tienen un papel fundamental en el seguimiento y valoración de la respuesta al tratamiento en pacientes oncológicos. La inmunoterapia es un desafío en el enfoque radiológico tanto para la valoración de la respuesta al tratamiento como para la correcta detección de los efectos adversos asociados.

Palabras clave:
Imagen en oncología
Terapia molecular dirigida
Criterios de respuesta inmunológica
Eventos adversos


These are the options to access the full texts of the publication Radiología (English Edition)

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos